Alacer Gold opens 4% higher in response to solid 2016 production and robust guidance for 2017
Alacer Gold is located in Turkey, a region which currently carries high sovereign risk. Those considering this stock as an investment should take this very high risk environment into account and seek independent financial advice for further information.
Alacer Gold Corporation (ASX: AQG) has achieved its best quarter of production for 2016 from the Copler gold project located in Turkey. The company announced its 2016 Results and Increased Production Guidance, which showed that in three months to December 31, 2016 AQG produced 33,800 ounces of gold, well above the previous quarter when production was 23,200 ounces.
This resulted in the company achieving full-year production of approximately 119,000 ounces, at the midpoint of December guidance which was in a range between 115,000 ounces and 125,000 ounces.
However, what may come as a surprise is the 2017 production guidance which is in a range between 160,000 ounces and 180,000 ounces. Analysts at Macquarie revised their figures in December and were forecasting production of 93,000 ounces in 2016, increasing to 121,700 ounces in 2017.
Alacer finished in a strong financial position being debt free and having a cash balance of $215 million.
In discussing the year ahead, Chief Executive Rod Antal said, “In addition to the higher gold production, 2017 will be a pivotal year for Alacer as we continue to execute on our organic growth strategy”.
On this note, the group will advance construction of the Copler sulphide expansion project, which is on schedule for maiden gold production in 2018.
Management also hasn’t discounted the prospect of acquisitions to complement the Copler project as it strives to become a sustainable multi-mine producer with a focus on Turkey.
It should be noted, however, that any further catalysts are speculative at this stage and should not be taken as guaranteed. Investors should seek professional financial advice for further information.
Short-term positions in small, early stage ASX companies,
with high potential and near term price catalysts.
Focusing on resource exploration, early-stage tech, and biotech.
Exceptional opportunities across a broad range of
early-stage growth sectors with strong management.
Seeking 1,000% plus returns across medium to long-term holds.
Longer-term positions in a variety of sectors.
Seeking strong management where traction is established and have entered into a growth phase.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.